Dschietzig, Thomas Bernd, and Guy Salama. “Relaxin-2 for Heart Failure With Preserved Ejection Fraction: A Comment on the Termination of a Phase-II Trial Investigating the Relaxin-2 Analogue, LY3540378”. Global Cardiology, vol. 2, no. 4, Dec. 2024, doi:10.4081/cardio.2024.56.